Ann Lab Med.  2014 Sep;34(5):386-389. 10.3343/alm.2014.34.5.386.

Presymptomatic Identification of CDH1 Germline Mutation in a Healthy Korean Individual with Family History of Gastric Cancer

• Choi HJ
• Ki CS
• Suh SP
• Kim JW

• KMID: 1791955
• DOI: http://doi.org/10.3343/alm.2014.34.5.386

Abstract

Gastric cancer (GC) is one of the most common cancers with high morbidity and mortality. Familial GC is seen in 10% of cases, and approximately 3% of familial GC cases arise owing to hereditary diffuse gastric cancer (HDGC). CDH1, which encodes the protein E-cadherin, is the only gene whose mutations are associated with HDGC. Screening for the familial GC-predisposing gene has been neglected in high-risk countries such as Korea, China, and Japan, where all the cases have been attributed to Helicobacter pylori or other carcinogens. Screening for the GC-causing CDH1 mutation may provide valuable information for genetic counseling, testing, and risk-reduction management for the as-yet unaffected family members. An asymptomatic 44-yr-old Korean male visited our genetic clinic for consultation owing to his family history of GC. Eventually, c.1018A>G in CDH1, a known disease-causing mutation, was found. As of the publication time, the individual is alive without the evidence of GC, and is on surveillance. To our knowledge, this is the first Korean case of presymptomatic detection of CDH1 mutation, and it highlights the importance of genetic screening for individuals with a family history of GC, especially in high-risk geographical areas.

Keyword

Stomach; Neoplasms; Hereditary; CDH1; Asymptomatic

MeSH Terms

Adult
Asian Continental Ancestry Group/*genetics
Cadherins/*genetics
Exons
Genetic Counseling
Genetic Predisposition to Disease
Genetic Testing
Germ-Line Mutation
Heterozygote
Humans
Male
Pedigree
Republic of Korea
Sequence Analysis, DNA
Stomach Neoplasms/*genetics/pathology
Cadherins

Figure

• 

  Fig. 1 Pedigree of the individual's family in our case. Solid symbol represents the individual with tumor(s). Types of tumors are indicated, along with ages (yr) at the time of diagnosis and death (if applicable). An asterisk (*) marks the examined individual found to carry the germline CDH1 mutation. Arrow indicates this case.Abbreviations: Dx, diagnosis; d, death; Ca, cancer.

• 

  Fig. 2 Sequence analysis of CDH1. Direct sequencing showed that he and his older brother he were heterozygous for a c.1018A>G mutation in exon 8, leading to the amino acid substitution from threonine to alanine.

Reference

1. Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract. 2012; 10:18.

2. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat. 2013; 45:15–21.

3. Choi IJ. Gastric cancer screening and diagnosis. Korean J Gastroenterol. 2009; 54:67–76.

4. Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer. 2011; 11:135–140.

5. Fujita H, Lennerz JK, Chung DC, Patel D, Deshpande V, Yoon SS, et al. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol. 2012; 36:1709–1717. PMID: 23073328.

6. Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012; 3:251–261. PMID: 22943016.

7. Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010; 47:436–444.

8. Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat. 2002; 19:510–517.

9. Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012; 12:8.

10. Pharoah PD, Guilford P, Caldas C. International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001; 121:1348–1353.

11. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007; 297:2360–2372.

12. Zhang Y, Liu X, Fan Y, Ding J, Xu A, Zhou X, et al. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. Int J Cancer. 2006; 119:2592–2596.

13. Kim HC, Wheeler JM, Kim JC, Ilyas M, Beck NE, Kim BS, et al. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut. 2000; 47:262–267.

14. Suriano G, Oliveira MJ, Huntsman D, Mateus AR, Ferreira P, Casares F, et al. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet. 2003; 12:3007–3016.

15. More H, Humar B, Weber W, Ward R, Christian A, Lintott C, et al. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat. 2007; 28:203.

16. Hamilton LE, Jones K, Church N, Medlicott S. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature. BMC Gastroenterol. 2013; 13:114.

17. Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006; 4:262–275.

18. Chen Y, Kingham K, Ford JM, Rosing J, Van Dam J, Jeffrey RB, et al. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol. 2011; 18:2594–2598.

19. Kim S, Chung JW, Jeong TD, Park YS, Lee JH, Ahn JY, et al. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients. Fam Cancer. 2013; 12:503–507.

20. Kim S, Ki CS, Kim KM, Lee MG, Kim S, Bae JM, et al. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma. BMB Rep. 2011; 44:725–729. PMID: 22118538.